Please use this identifier to cite or link to this item:
Title: Changing Management of Hematological Malignancies With COVID-19: Statement and Recommendations of the Lebanese Society of Hematology and Blood Transfusion
Authors: Ibrahim, Ahmad
Noun, Peter
Khalil, Charbel
Taher, Ali
Affiliations: Faculty of Medicine 
Keywords: LSHBT
SARS-Cov-2 infection
Hematological malignancies
Issue Date: 2021
Part of: Frontiers in oncology
Volume: 11
COVID-19 caused by SARS-Cov-2 is a devastating infection in patients with hematological malignancies. In 2018, the Lebanese Society of Hematology and Blood Transfusion (LSHBT) updated the guidelines for the management of hematological malignancies in Lebanon. In 2019, it was followed by a second update. Given the rapidly changing evidence and general situation for COVID-19, the LSHBT established some recommendations and suggestions for the management of the patients with hematological malignancies taking into account the Lebanese condition, economic situation, and the facts that SARS-Cov-2 infection has apparently been devastating. In this article we present recommendations and proposals to reduce or to manage SARS-Cov-2 infection in the patients with myeloid and lymphoid hematological malignancies.
ISSN: 2234-943X
DOI: 10.3389/fonc.2021.564383
Open URL: Link to full text
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record


checked on Dec 3, 2022

Record view(s)

checked on Dec 3, 2022

Google ScholarTM


Dimensions Altmetric

Dimensions Altmetric

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.